Afrezza

Active Ingredient(s): Insulin Human
FDA Approved: * June 27, 2014
Pharm Company: * MANNKIND CORP
Category: Diabetes

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Afrezza Overview

Insulin is a protein hormone that is used as a medication to treat high blood glucose.[3] This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states.[3] It is also used along with glucose to treat high blood potassium levels.[4] Typically it is given by injection under the skin, but some forms may also be used by inje...

Read more Afrezza Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Insulin_therapy

Recent Afrezza Forums: RSS Feed

Afrezza- Has anyone seen marketing information on this

Has anyone seen the marketing information presented by Sanofi? ## @Cbondfrac, Sanofi doesn't appear to list anything about Afrezza on their webpage, so I'm not sure where one might go to find the specific type of marketing information you're seeking from them. But from what I've seen online, it looks like several other sites do list details on Afrezza. Apparently it's reported to be a type of "rapid acting inhaled insulin", prescribed to improve glycemic control in patients who are challenged with diabetes mellitus. Here's a PDF from the manufacturer with some additional prescribing information: mannkindcorp.com/Collateral/Documents/English-US/Afrezza_PrescribingInformation.pdf I hope this helps answer your question! ## David- Thank you for the informatio...

Updated

Possible Dosages for this and Related Drugs:

Insulin Human
  • Injection: 100 units/ml, 100unit/ml, 100units/ml, 40 units/ml, 500unit/ml
  • Powder: 12 Units/inh, 4 Units, 4 Units/inh, 8 Units, 8 Units/inh
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Afrezza: (13 results)

Sorted by National Drug Code
  • 0024-5874 Afrezza 4 1/1 Respiratory (Inhalation) Powder, Metered by Sanofi-aventis U.S. LLC
  • 0024-5882 Afrezza Kit by Sanofi-aventis U.S. LLC
  • 0024-5884 Afrezza Kit by Sanofi-aventis U.S. LLC
  • 0024-5894 Afrezza Kit by Sanofi-aventis U.S. LLC
  • 47918-874 Afrezza 4 1/1 Respiratory (Inhalation) Powder, Metered by Mannkind Corporation
  • 47918-878 Afrezza 8 1/1 Respiratory (Inhalation) Powder, Metered by Mannkind Corporation
  • 47918-880 Afrezza Kit by Mannkind Corporation
  • 47918-882 Afrezza Kit by Mannkind Corporation
  • 47918-884 Afrezza Kit by Mannkind Corporation
  • 47918-891 Afrezza 12 1/1 Respiratory (Inhalation) Powder, Metered by Mannkind Corporation
  • 47918-894 Afrezza Kit by Mannkind Corporation
  • 47918-898 Afrezza Kit by Mannkind Corporation
  • 47918-902 Afrezza Kit by Mannkind Corporation

Other drugs which contain Insulin Human or a similar ingredient: (1 result)

Related Afrezza Topics:

Afrezza- Has anyone seen marketing information on this
Has anyone seen the marketing information presented by Sanofi? ## @Cbondfrac, Sanofi doesn't appear to list anything... 2 replies






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA